Page last updated: 2024-08-24

fluorodeoxyglucose f18 and Hormone-Dependent Neoplasms

fluorodeoxyglucose f18 has been researched along with Hormone-Dependent Neoplasms in 9 studies

Research

Studies (9)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (11.11)	18.2507
2000's	3 (33.33)	29.6817
2010's	5 (55.56)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bernardi, A; Cacciari, N; Fanti, S; Martoni, AA; Musto, A; Quercia, S; Rosati, M; Santini, D; Taffurelli, M; Zamagni, C	1
Calaminus, C; Duchamp, O; Honndorf, VS; Judenhofer, MS; Kukuk, D; Machulla, HJ; Pichler, BJ; Quintanilla-Martinez, L; Raguin, O; Reischl, G; Schönberger, T; Wiehr, S	1
Kimura, H; Kiyono, Y; Maeda, H; Mori, T; Okazawa, H; Tsuchida, T; Tsujikawa, T; Yoshida, Y	1
Cheze-Le Rest, C; de Roquancourt, A; Espié, M; Giacchetti, S; Groheux, D; Hatt, M; Hindié, E; Martineau, A; Visvikis, D	1
Cheng, J; Lei, L; Liu, G; Pan, L; Shao, Z; Sun, Y; Wang, X; Xu, J; Zhang, Y	1
Bénard, F; Langlois, MF; Leboeuf, R	1
Hayashi, M; Murakami, K; Oyama, T; Shimoda, W; Sunagawa, M	1
Alavi, A; Basu, S; Cermik, T; Chen, W; Czerniecki, B; Mavi, A; Schnall, M; Tchou, J	1
Finn, RD; Garza, D; Goldsmith, SJ; Horowitz, SM; Imbriaco, M; Kalaigian, H; Larson, SM; Reddy, D; Scher, HI; Yeh, SD; Zhang, JJ	1

Trials

2 trial(s) available for fluorodeoxyglucose f18 and Hormone-Dependent Neoplasms

Article	Year
Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for d Cancer, 2008, Mar-01, Volume: 112, Issue:5 Topics: Adult; Aged; Breast Neoplasms; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasms, Hormone-Dependent; Positron-Emission Tomography; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Sensitivity and Specificity; Tomography, Emission-Computed	2008
Detection of bony metastases of androgen-independent prostate cancer by PET-FDG. Nuclear medicine and biology, 1996, Volume: 23, Issue:6 Topics: Aged; Androgens; Bone Neoplasms; Deoxyglucose; Evaluation Studies as Topic; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glycolysis; Humans; Male; Middle Aged; Neoplasms, Hormone-Dependent; Prostatic Neoplasms; Technetium Tc 99m Medronate; Tomography, Emission-Computed	1996

Article

Year

Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for d

Cancer, 2008, Mar-01, Volume: 112, Issue:5

Topics: Adult; Aged; Breast Neoplasms; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasms, Hormone-Dependent; Positron-Emission Tomography; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Sensitivity and Specificity; Tomography, Emission-Computed

2008

Detection of bony metastases of androgen-independent prostate cancer by PET-FDG.

Nuclear medicine and biology, 1996, Volume: 23, Issue:6

Topics: Aged; Androgens; Bone Neoplasms; Deoxyglucose; Evaluation Studies as Topic; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glycolysis; Humans; Male; Middle Aged; Neoplasms, Hormone-Dependent; Prostatic Neoplasms; Technetium Tc 99m Medronate; Tomography, Emission-Computed

1996

Other Studies

7 other study(ies) available for fluorodeoxyglucose f18 and Hormone-Dependent Neoplasms

Article	Year
Early (18)F-2-fluoro-2-deoxy-d-glucose positron emission tomography may identify a subset of patients with estrogen receptor-positive breast cancer who will not respond optimally to preoperative chemotherapy. Cancer, 2010, Feb-15, Volume: 116, Issue:4 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoadjuvant Therapy; Neoplasm, Residual; Neoplasms, Hormone-Dependent; Positron-Emission Tomography; Prognosis; Receptors, Estrogen; Treatment Outcome	2010
Assessment of PET tracer uptake in hormone-independent and hormone-dependent xenograft prostate cancer mouse models. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2011, Volume: 52, Issue:10 Topics: Animals; Carbon Radioisotopes; Cell Line, Tumor; Choline; Dideoxynucleosides; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Male; Mice; Neoplasm Transplantation; Neoplasms, Hormone-Dependent; Orchiectomy; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Transplantation, Heterologous	2011
Oestrogen-related tumour phenotype: positron emission tomography characterisation with ¹⁸F-FDG and ¹⁸F-FES. The British journal of radiology, 2012, Volume: 85, Issue:1015 Topics: Aged; Breast Neoplasms; Contrast Media; Endometrial Neoplasms; Estrogens; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Middle Aged; Neoplasms, Hormone-Dependent; Phenotype; Positron-Emission Tomography; Sensitivity and Specificity	2012
Comparison between 18F-FDG PET image-derived indices for early prediction of response to neoadjuvant chemotherapy in breast cancer. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2013, Volume: 54, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cohort Studies; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Neoadjuvant Therapy; Neoplasms, Hormone-Dependent; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Retrospective Studies; Treatment Outcome	2013
18F-fluoromisonidazole PET/CT: a potential tool for predicting primary endocrine therapy resistance in breast cancer. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2013, Volume: 54, Issue:3 Topics: Aged; Aged, 80 and over; Aromatase Inhibitors; Breast Neoplasms; Drug Resistance, Neoplasm; Estrogen Receptor alpha; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Immunohistochemistry; Ki-67 Antigen; Letrozole; Middle Aged; Misonidazole; Multimodal Imaging; Neoplasms, Hormone-Dependent; Nitriles; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Triazoles	2013
Thyroid cancer presenting as a PET incidentaloma in a patient with concomitant breast cancer metastases to the thyroid. Clinical nuclear medicine, 2006, Volume: 31, Issue:7 Topics: Adrenal Gland Neoplasms; Antineoplastic Agents, Hormonal; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Papillary; Chemotherapy, Adjuvant; Combined Modality Therapy; Disease Progression; Estrogens; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Iodine Radioisotopes; Lung Neoplasms; Mastectomy, Segmental; Mediastinal Neoplasms; Middle Aged; Neoplasm Proteins; Neoplasms, Hormone-Dependent; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy, Adjuvant; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen; Thyroid Neoplasms; Tomography, X-Ray Computed; Ultrasonography	2006
The relationship between FDG uptake in PET scans and biological behavior in breast cancer. Breast cancer (Tokyo, Japan), 2007, Volume: 14, Issue:3 Topics: Adenocarcinoma, Scirrhous; Adult; Aged; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Fluorodeoxyglucose F18; Humans; Injections, Intravenous; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Neoplasms, Hormone-Dependent; Positron-Emission Tomography; Radiopharmaceuticals; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone	2007